Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

about

Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells.Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.

P2860

Q40018413-78878C18-0669-4C7C-93CF-7DE1E97260CA Q50718386-95B231F5-33C1-44E9-8806-BD8F184ACAE1

P2860

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

Item

http://www.wikidata.org/entity/Q43790335

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

@en

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

@nl

type

Item

label

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

@en

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

@nl

prefLabel

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

@en

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

@nl

P1476

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

@en

P2093

Aktas O

http://www.w3.org/2001/XMLSchema#string

Ari N

http://www.w3.org/2001/XMLSchema#string

Hoffmann V

http://www.w3.org/2001/XMLSchema#string

Przuntek H

http://www.w3.org/2001/XMLSchema#string

Pöhlau D

http://www.w3.org/2001/XMLSchema#string

Rieks M

http://www.w3.org/2001/XMLSchema#string

Schimrigk S

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

Multiple sclerosis

Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1

Immunopathogenesis of multiple sclerosis: the role of T cells.

Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadi

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

P304

266-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1600-0404.2001.00125.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11696019

http://www.w3.org/2001/XMLSchema#string

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

about

P2860

P2860

Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698